Rosen, top-ranked investor counsel, encourages bioage labs, inc. investors to secure counsel before important deadline in securities class action - bioa

New york, ny / access newswire / february 10, 2025 / why: rosen law firm, a global investor rights law firm, reminds purchasers of stock of bioage labs, inc. (nasdaq:bioa) pursuant and/or traceable to bioage's registration statement for the initial public offering conducted on september 26, 2024 (the "ipo"), of the important march 10, 2025 lead plaintiff deadline. so what: if you purchased bioage stock you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
TOP Ratings Summary
TOP Quant Ranking